Top Markets
#1 Glidr Glidr +51.75%
#2 DOVU DOVU +47.62%
#3 Akedo Akedo +43.85%
#4 Velvet Velvet +39.70%
#5 Black Phoenix Black Phoenix +34.25%
#6 Cross Cross +26.33%
#7 Perle Perle +18.76%
#8 Cysic Cysic +18.58%
#9 Bitway Bitway +15.04%
#10 QANplatform QANplatform +14.82%
Coin of the day
Glidr Glidr
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Oventus Medical Limited Oventus Medical Limited

Oventus Medical Limited

OVN
Rang in aandelen #38493
Oventus Medical Limited is a medical device enterprise focused on the creation... Oventus Medical Limited is a medical device enterprise focused on the creation and commercialization of oral appliances designed to alleviate obstructive sleep apnea (OSA) and snoring. The company distributes its solutions across Australia, Canada, and the United States. Key offerings include the O2Vent Optima, a custom 3D-printed nylon oral appliance developed for OSA patients, and ExVent, a valve accessory specifically designed to fit into the O2Vent Optima's airway. Established in 2015, the firm's main office is located in Indooroopilly, Australia.
Aandeelprijs
$0.01322533
Laatst gesynchroniseerd: 2023-05-23
Marktkapitalisatie
$949.73K
Verandering (1 dag)
-0.56%
Verandering (1 jaar)
0.00%
Land
AU
Handel Oventus Medical Limited (OVN)

Categorie

Healthcare
P/S-ratio voor Oventus Medical Limited (OVN)
P/S-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Oventus Medical Limited is de huidige P/S-ratio (TTM) 0. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor Oventus Medical Limited van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
3.95 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
4.83 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.31 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
7.61 -
US